Beneficient (BENFW) Common Equity (2020 - 2025)

Beneficient has disclosed Common Equity across 6 years of filings, most recently posting -$128.6 million for Q4 2025.

• Common Equity for Q4 2025 came in at -$128.6 million, down 1001.59% year-over-year; the trailing twelve-month figure through Dec 2025 was -$128.6 million (down 1001.59% YoY), and the FY2025 annual result was -$34.9 million, up 81.82% from the prior year.
• Common Equity came in at -$128.6 million for Q4 2025 at Beneficient, up from -$142.8 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.9 billion in Q1 2022 to a low of -$192.1 million in Q1 2024.
• The 5-year median for Common Equity is $14.3 million (2024), against an average of $636.1 million.
• Across the five-year window, Common Equity soared 258.92% in 2024 and slumped 1001.59% in 2025, its largest moves.
• Beneficient's Common Equity stood at $1.1 billion in 2021, then soared by 65.19% to $1.8 billion in 2022, then sank by 99.78% to $4.0 million in 2023, then jumped by 258.92% to $14.3 million in 2024, then plunged by 1001.59% to -$128.6 million in 2025.
• The last three Common Equity figures came in at -$128.6 million (Q4 2025), -$142.8 million (Q3 2025), and -$120.4 million (Q2 2025), per Business Quant data.